{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:55:09Z","timestamp":1792691709505,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174158"],"award-info":[{"award-number":["82174158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010032","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","award":["202340293"],"award-info":[{"award-number":["202340293"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.brainresbull.2026.111990","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:49:09Z","timestamp":1780555749000},"page":"111990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The role of Th17 cells in the pathogenesis of Parkinson's disease: From immune dysregulation to neurodegeneration"],"prefix":"10.1016","volume":"242","author":[{"given":"Jinyue","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9097-7357","authenticated-orcid":false,"given":"Huazheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.brainresbull.2026.111990_bib1","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/cimb44050127","article-title":"The treatment with interleukin 17 inhibitors and immune-mediated inflammatory diseases","volume":"44","author":"\u021aiburc\u0103","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"issue":"2","key":"10.1016\/j.brainresbull.2026.111990_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1063","article-title":"Pros and cons for statins use and risk of Parkinson's disease: an updated perspective","volume":"11","author":"Al-kuraishy","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"issue":"22","key":"10.1016\/j.brainresbull.2026.111990_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216288","article-title":"Blood\u2013brain barrier breakdown in alzheimer\u2019s disease: mechanisms and targeted strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.brainresbull.2026.111990_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11010-023-04771-7","article-title":"Metformin role in Parkinson\u2019s disease: a double-sword effect","volume":"479","author":"Alrouji","year":"2023","journal-title":"Mol. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.brainresbull.2026.111990_bib5","doi-asserted-by":"crossref","first-page":"15108","DOI":"10.1007\/s12035-025-05113-y","article-title":"Targeting of the PI3 K\/AKT\/GSK3\u03b2 pathway in Parkinson's disease: a therapeutic blueprint","volume":"62","author":"AlRuwaili","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.brainresbull.2026.111990_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70721","article-title":"Differential Roles of Angiotensin A and Alamandine in Parkinson's disease: a therapeutic perspective on nonclassical RAS pathways","volume":"15","author":"Alshehri","year":"2025","journal-title":"Brain Behav."},{"issue":"10","key":"10.1016\/j.brainresbull.2026.111990_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.it.2012.05.004","article-title":"Defining the human T helper 17 cell phenotype","volume":"33","author":"Annunziato","year":"2012","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11481-012-9401-0","article-title":"Microglial activation and antioxidant responses induced by the parkinson\u2019s disease protein \u03b1-synuclein","volume":"8","author":"B\u00e9raud","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"10423","key":"10.1016\/j.brainresbull.2026.111990_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02296-8","article-title":"T-cell dysregulation is associated with disease severity in Parkinson\u2019s Disease","volume":"18","author":"Bhatia","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.brainresbull.2026.111990_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578610","article-title":"Sex-specific immune-biological profiles in Parkinson's disease","volume":"403","author":"Bovenzi","year":"2025","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12974-016-0588-5","article-title":"Inflammatory profile in LRRK2-associated prodromal and clinical PD","volume":"13","author":"Brockmann","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.brainresbull.2026.111990_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000870","article-title":"Interleukin-26, preferentially produced by TH17 lymphocytes, regulates CNS barrier function","volume":"7","author":"Broux","year":"2020","journal-title":"Neurol. Neuroimmunol. & Neuroinflamm."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebri\u00e1n","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainresbull.2026.111990_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.566922","article-title":"Interleukin-17A: the key cytokine in neurodegenerative diseases","volume":"12","author":"Chen","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.brainresbull.2026.111990_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainresbull.2021.09.010","article-title":"Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson\u2019s disease","volume":"177","author":"Chen","year":"2021","journal-title":"Brain Res. Bull."},{"issue":"8","key":"10.1016\/j.brainresbull.2026.111990_bib17","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbi.2012.08.013","article-title":"Neuro-protective effects of bee venom by suppression of neuroinflammatory responses in a mouse model of Parkinson's disease: role of regulatory T cells","volume":"26","author":"Chung","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.brainresbull.2026.111990_bib18","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.4049\/jimmunol.1500386","article-title":"Bee Venom Phospholipase A2, a Novel Foxp3+ Regulatory T Cell Inducer, Protects Dopaminergic Neurons by Modulating Neuroinflammatory Responses in a Mouse Model of Parkinson\u2019s Disease","volume":"195","author":"Chung","year":"2015","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.brainresbull.2026.111990_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41380-024-02618-1","article-title":"Abatacept inhibits Th17 differentiation and mitigates \u03b1-synuclein-induced dopaminergic dysfunction in mice","volume":"30","author":"Clarke","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib20","article-title":"Microglia Acquire Distinct Activation Profiles Depending on the Degree of \u03b1-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease","volume":"5","author":"Cookson","year":"2010","journal-title":"PLoS. ONE"},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","article-title":"Parkinson's Disease: A Multisystem Disorder","volume":"39","author":"Costa","year":"2022","journal-title":"Neurosci. Bull."},{"issue":"6","key":"10.1016\/j.brainresbull.2026.111990_bib22","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ajpath.2014.02.004","article-title":"IL-27R\u2013Mediated Regulation of IL-17 Controls the Development of Respiratory Syncytial Virus\u2013Associated Pathogenesis","volume":"184","author":"de Almeida Nagata","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuron.2018.11.005","article-title":"A Neural Circuit Mechanism for Encoding Aversive Stimuli in the Mesolimbic Dopamine System","volume":"101","author":"de Jong","year":"2019","journal-title":"Neuron"},{"issue":"90","key":"10.1016\/j.brainresbull.2026.111990_bib24","article-title":"Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson\u2019s disease patients","volume":"2","author":"Doorn","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1636-8","article-title":"Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice","volume":"16","author":"Earls","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.brainresbull.2026.111990_bib26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF","volume":"12","author":"El-Behi","year":"2011","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.brainresbull.2026.111990_bib27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2026.111990_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02171","article-title":"Protective and Regenerative Roles of T Cells in Central Nervous System Disorders","volume":"10","author":"Evans","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41531-025-01212-8","article-title":"Immune and metabolic signatures characterise constipation-driven endophenotypes in Parkinson\u2019s disease","volume":"12","author":"Figliomeni","year":"2025","journal-title":"npj Park. 's. Dis."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12974-022-02446-6","article-title":"The role of Th17 cells\/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A","volume":"19","author":"Fu","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12974-025-03359-w","article-title":"\u03b1-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson\u2019s disease","volume":"22","author":"Furusawa-Nishii","year":"2025","journal-title":"J. Neuroinflamm."},{"issue":"21","key":"10.1016\/j.brainresbull.2026.111990_bib32","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1016\/j.neuron.2023.07.015","article-title":"Interaction of an \u03b1-synuclein epitope with HLA-DRB1\u221715:01 triggers enteric features in mice reminiscent of prodromal Parkinson\u2019s disease","volume":"111","author":"Garretti","year":"2023","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13024-023-00686-5","article-title":"MLKL deficiency alleviates neuroinflammation and motor deficits in the alpha-synuclein transgenic mouse model of Parkinson's disease","volume":"18","author":"Geng","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"7318","key":"10.1016\/j.brainresbull.2026.111990_bib34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic TH17 cells in the absence of TGF-\u03b2 signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1474-4422(25)00386-2","article-title":"Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial","volume":"25","author":"Greenland","year":"2026","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.brainresbull.2026.111990_bib36","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1096\/fj.201900992R","article-title":"TREM2 deficiency aggravates \u03b1-synuclein\u2013induced neurodegeneration and neuroinflammation in Parkinson's disease models","volume":"33","author":"Guo","year":"2019","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.brainresbull.2026.111990_bib37","doi-asserted-by":"crossref","first-page":"9592","DOI":"10.1523\/JNEUROSCI.5610-12.2013","article-title":"MHCII Is Required for \u03b1-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration","volume":"33","author":"Harms","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2026.111990_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.expneurol.2017.11.010","article-title":"Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease","volume":"300","author":"Harms","year":"2018","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.brainresbull.2026.111990_bib39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.brainresbull.2026.111990_bib40","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17\u2013producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.brainresbull.2026.111990_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.819224","article-title":"CCR6 and CXCR6 Identify the Th17 Cells With Cytotoxicity in Experimental Autoimmune Encephalomyelitis","volume":"13","author":"Hou","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.brainresbull.2026.111990_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11302-025-10114-6","article-title":"The potential role of adenosinergic pathway and methylxanthines in Parkinson\u2019s disease: Blowing in the wind or not","volume":"22","author":"Ismail","year":"2026","journal-title":"Purinergic Signal."},{"issue":"3","key":"10.1016\/j.brainresbull.2026.111990_bib43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.brainresbull.2026.111990_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.850616","article-title":"Contact-Dependent Granzyme B-Mediated Cytotoxicity of Th17-Polarized Cells Toward Human Oligodendrocytes","volume":"13","author":"Jamann","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.brainresbull.2026.111990_bib45","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10072-017-2988-4","article-title":"The correlation of lymphocyte subsets, natural killer cell, and Parkinson\u2019s disease: a meta-analysis","volume":"38","author":"Jiang","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2026.111990_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578484","article-title":"The role of the immune system in Parkinson's disease pathogenesis: A focus on Th17 cells - A systematic review and meta-analysis","volume":"398","author":"Jiang","year":"2025","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.brainresbull.2026.111990_bib47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.brainresbull.2026.111990_bib48","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"issue":"1-2","key":"10.1016\/j.brainresbull.2026.111990_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.10.009","article-title":"GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice","volume":"265","author":"Kosloski","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"50","key":"10.1016\/j.brainresbull.2026.111990_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba4163","article-title":"Pathogen-induced tissue-resident memory TH17 (TRM17) cells amplify autoimmune kidney disease","volume":"5","author":"Krebs","year":"2020","journal-title":"Sci. IMMUNOLOGY"},{"issue":"9","key":"10.1016\/j.brainresbull.2026.111990_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12090880","article-title":"Drugs Modulating CD4+ T Cells Blood\u2013Brain Barrier Interaction in Alzheimer\u2019s Disease","volume":"12","author":"Kubick","year":"2020","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.brainresbull.2026.111990_bib52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.immuni.2016.02.007","article-title":"Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation","volume":"44","author":"Kumar","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40035-024-00410-3","article-title":"The role of the brain renin-angiotensin system in Parkinson\u00b4s disease","volume":"13","author":"Labandeira-Garcia","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"120","key":"10.1016\/j.brainresbull.2026.111990_bib55","article-title":"Multiancestry analysis of the HLA locus in Alzheimer\u2019s and Parkinson\u2019s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes","volume":"36","author":"Le Guen","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainresbull.2026.111990_bib56","article-title":"Inflammatory bowel disease and Parkinson\u2019s disease: common pathophysiological links","author":"Lee","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.brainresbull.2026.111990_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2022.10.023","article-title":"\u03b1-Synuclein induces Th17 differentiation and impairs the function and stability of Tregs by promoting RORC transcription in Parkinson's disease","volume":"108","author":"Li","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.brainresbull.2026.111990_bib58","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1007\/s10753-025-02267-8","article-title":"FDA-Approved Secukinumab Alleviates Glial Activation and Immune Cell Infiltration in MPTP-Induced Mouse Model of Parkinson\u2019s Disease","volume":"48","author":"Li","year":"2025","journal-title":"Inflammation"},{"issue":"7638","key":"10.1016\/j.brainresbull.2026.111990_bib59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15626-w","article-title":"\u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease","volume":"11","author":"Lindestam Arlehamn","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainresbull.2026.111990_bib61","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","article-title":"IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease","volume":"81","author":"Liu","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainresbull.2026.111990_bib62","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2021.08.220","article-title":"Dopamine receptor D2 on CD4+ T cells is protective against neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease","volume":"98","author":"Liu","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib63","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1038\/s41467-025-62478-3","article-title":"The spatial landscape of glial pathology and T cell response in Parkinson\u2019s disease substantia nigra","volume":"16","author":"Ma","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00375-7","article-title":"Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders","volume":"15","author":"Machhi","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"11","key":"10.1016\/j.brainresbull.2026.111990_bib65","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/glia.24601","article-title":"CD4+ T cell-associated cytokines induce a chronic pro-inflammatory phenotype in induced pluripotent stem cell-derived midbrain astrocytes","volume":"72","author":"MacMahon Copas","year":"2024","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11481-019-09852-3","article-title":"Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions","volume":"15","author":"Melnikov","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"10423","key":"10.1016\/j.brainresbull.2026.111990_bib68","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.brainresbull.2026.111990_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102647","article-title":"The role of TH17 cells in multiple sclerosis: Therapeutic implications","volume":"19","author":"Moser","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.brainresbull.2026.111990_bib70","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1474-4422(17)30276-4","article-title":"T cells and Parkinson's disease","volume":"16","author":"Mosley","year":"2017","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.brainresbull.2026.111990_bib71","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4093\/dmj.2024.0140","article-title":"T-Cell Senescence in Human Metabolic Diseases","volume":"48","author":"Nga","year":"2024","journal-title":"Diabetes & Metab. J."},{"issue":"2","key":"10.1016\/j.brainresbull.2026.111990_bib72","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","article-title":"Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson\u2019s Disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Trends Neurosci."},{"issue":"50","key":"10.1016\/j.brainresbull.2026.111990_bib73","doi-asserted-by":"crossref","first-page":"16463","DOI":"10.1523\/JNEUROSCI.2131-15.2015","article-title":"Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice","volume":"35","author":"Olson","year":"2015","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.brainresbull.2026.111990_bib74","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s12276-025-01535-9","article-title":"Th17 cell pathogenicity in autoimmune disease","volume":"57","author":"Park","year":"2025","journal-title":"Exp. & Mol. Med."},{"issue":"11","key":"10.1016\/j.brainresbull.2026.111990_bib75","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"issue":"7970","key":"10.1016\/j.brainresbull.2026.111990_bib76","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","article-title":"Co-transplantation of autologous Treg cells in a cell therapy for Parkinson\u2019s disease","volume":"619","author":"Park","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.brainresbull.2026.111990_bib77","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1073\/pnas.1911097117","article-title":"Th17 lymphocytes drive vascular and neuronal deficits in a mouse model of postinfectious autoimmune encephalitis","volume":"117","author":"Platt","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib78","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.brainresbull.2026.111990_bib79","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol."},{"issue":"6301","key":"10.1016\/j.brainresbull.2026.111990_bib80","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.brainresbull.2026.111990_bib81","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease","volume":"184","author":"Reynolds","year":"2010","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.brainresbull.2026.111990_bib82","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson's disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.brainresbull.2026.111990_bib83","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib84","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-022-01387-9","article-title":"TH17 cell heterogeneity and its role in tissue inflammation","volume":"24","author":"Schnell","year":"2023","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib85","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-018-0255-7","article-title":"Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson\u2019s disease","volume":"13","author":"Schutt","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainresbull.2026.111990_bib86","article-title":"Th17 cells and inflammation in neurological disorders: Possible mechanisms of action","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07053-9","article-title":"Tissue-resident memory T cells populate the human brain","volume":"9","author":"Smolders","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib88","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","article-title":"Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease","volume":"23","author":"Sommer","year":"2018","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.brainresbull.2026.111990_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1340110","article-title":"Association of immune cell traits with Parkinson\u2019s disease: a Mendelian randomization study","volume":"16","author":"Song","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.brainresbull.2026.111990_bib90","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fneur.2019.00013","article-title":"Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence","volume":"10","author":"Storelli","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.brainresbull.2026.111990_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.769506","article-title":"Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson\u2019s Disease","volume":"13","author":"Su","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"7660","key":"10.1016\/j.brainresbull.2026.111990_bib92","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.brainresbull.2026.111990_bib93","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2019.10.105","article-title":"Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson\u2019s disease","volume":"7","author":"Sun","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.brainresbull.2026.111990_bib94","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/d41586-023-02177-5","article-title":"Regulatory T cells aid stem-cell therapy for Parkinson's disease","volume":"619","author":"Tang","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.brainresbull.2026.111990_bib95","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp3+ regulatory T cell: a jack of all trades, master of regulation","volume":"9","author":"Tang","year":"2008","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.brainresbull.2026.111990_bib96","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"s1","key":"10.1016\/j.brainresbull.2026.111990_bib97","first-page":"S149","article-title":"Neuroinflammation and immune changes in prodromal Parkinson\u2019s disease and other synucleinopathies","volume":"12","author":"Terkelsen","year":"2022","journal-title":"J. Park. 's. Dis."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib98","article-title":"Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson\u2019s disease","volume":"7","author":"Thome","year":"2021","journal-title":"npj Park. 's. Dis."},{"issue":"8","key":"10.1016\/j.brainresbull.2026.111990_bib99","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00702-016-1667-6","article-title":"Parkinson\u2019s: a syndrome rather than a disease?","volume":"124","author":"Titova","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainresbull.2026.111990_bib100","doi-asserted-by":"crossref","DOI":"10.1177\/08919887251409836","article-title":"The possible impact of montelukast in Parkinson\u2019s disease: a substantial contribution","author":"Turkistani","year":"2026","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"5","key":"10.1016\/j.brainresbull.2026.111990_bib101","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-015-1402-7","article-title":"The role of IL-17 in CNS diseases","volume":"129","author":"Waisman","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.brainresbull.2026.111990_bib102","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11064-025-04559-9","article-title":"The mitochondrial-astrocyte-neuron triad hypothesis in Parkinson\u2019s disease: a toxic feedback loop of metabolism, aggregation, and oxidative stress","volume":"50","author":"Walecha","year":"2025","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.brainresbull.2026.111990_bib103","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.30144","article-title":"Effects of montelukast on neuroinflammation in Parkinson's disease: an open label safety and tolerability trial with CSF markers and [11C]PBR28 PET","volume":"40","author":"Wallin","year":"2025","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib104","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-024-00448-3","article-title":"Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson\u2019s model","volume":"13","author":"Weiss","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"7","key":"10.1016\/j.brainresbull.2026.111990_bib105","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.brainresbull.2026.111990_bib106","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mds.26563","article-title":"Serum immune markers and disease progression in an incident Parkinson's disease cohort ( ICICLE-PD","volume":"31","author":"Williams-Gray","year":"2016","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.brainresbull.2026.111990_bib107","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.immuni.2020.12.010","article-title":"The TGF-\u03b2 superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation","volume":"54","author":"Wu","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib108","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-024-00770-4","article-title":"Repetitive transcranial magnetic stimulation alleviates motor impairment in Parkinson\u2019s disease: association with peripheral inflammatory regulatory T-cells and SYT6","volume":"19","author":"Xie","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainresbull.2026.111990_bib109","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bbi.2024.10.025","article-title":"Bidirectional interaction between IL and 17A\/IL-17RA pathway dysregulation and \u03b1-synuclein in the pathogenesis of Parkinson\u2019s disease","volume":"123","author":"Yan","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.brainresbull.2026.111990_bib110","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001036","article-title":"Dysregulation of the adaptive immune system in patients with early-stage Parkinson disease","volume":"8","author":"Yan","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.brainresbull.2026.111990_bib111","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12974-018-1053-4","article-title":"MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson\u2019s disease","volume":"15","author":"Yao","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.brainresbull.2026.111990_bib112","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1096\/fj.201900363R","article-title":"MicroRNA-124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease","volume":"33","author":"Yao","year":"2019","journal-title":"FASEB J."},{"issue":"30","key":"10.1016\/j.brainresbull.2026.111990_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303711","article-title":"LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1\/TGF-\u03b21 in Parkinson's Disease","volume":"10","author":"Yao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.brainresbull.2026.111990_bib114","article-title":"Centenarians alleviate inflammaging by changing the ratio and secretory phenotypes of T helper 17 and regulatory T cells","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923026002765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923026002765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:24:41Z","timestamp":1783441481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923026002765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":114,"alternative-id":["S0361923026002765"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2026.111990","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of Th17 cells in the pathogenesis of Parkinson's disease: From immune dysregulation to neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2026.111990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111990"}}